Regenxbio Net Tangible Assets from 2010 to 2024

RGNX Stock  USD 9.58  0.01  0.10%   
Regenxbio Net Tangible Assets yearly trend continues to be fairly stable with very little volatility. Net Tangible Assets will likely drop to about 386.3 M in 2024. Net Tangible Assets is the total assets of Regenxbio minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2014-12-31
Previous Quarter
516.2 M
Current Value
465.1 M
Quarterly Volatility
178.7 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Regenxbio over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Regenxbio's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Slightly volatile
   Net Tangible Assets   
       Timeline  

Regenxbio Net Tangible Assets Regression Statistics

Arithmetic Mean271,155,109
Coefficient Of Variation96.67
Mean Deviation226,549,582
Median216,808,000
Standard Deviation262,131,620
Sample Variance68713T
Range782.6M
R-Value0.87
Mean Square Error17754.2T
R-Squared0.76
Significance0.000023
Slope51,101,365
Total Sum of Squares961981.8T

Regenxbio Net Tangible Assets History

2024386.3 M
2023593.6 M
2022516.2 M
2021764.3 M
2020377.8 M
2019450.2 M
2018508.8 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Tangible Assets593.6 M386.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.